CENOVARI THERAPEUTICS
Live / Applied — First extension granted (statement of use) (as of 26 Mar 2026)
What this means for you
Not registered yet, but its 03 Mar 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99064739
- Mark type
- Stylized text
- Filed
- 03 Mar 2025
- Published for opposition
- 16 Sept 2025
- Attorney of record
- Perry J. Viscounty
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of cancer and blood diseases and disorders; Pharmaceutical preparations and substances for use in oncology
Owner
- Cenovari Therapeutics, Inc., Agoura Hills, CA, US
- Cenovari Therapeutics, Inc., Agoura Hills, CA, US
Prosecution history
- 27 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Mar 2026 — SOU EXTENSION 1 GRANTED
- 26 Mar 2026 — SOU EXTENSION 1 FILED
- 26 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 11 Nov 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 16 Sept 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 Sept 2025 — PUBLISHED FOR OPPOSITION
- 10 Sept 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Aug 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 12 Aug 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 12 Aug 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 12 Aug 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 11 Aug 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 11 Aug 2025 — NON-FINAL ACTION E-MAILED
- 11 Aug 2025 — NON-FINAL ACTION WRITTEN